RecruitingPhase 2NCT05039619A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric ParticipantsSponsor: Hoffmann-La RocheCincinnati, OH · +10 more sites
RecruitingPhase 3NCT05835310An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric ParticipantsSponsor: AstraZenecaCincinnati, OH · Cleveland, OH · Columbus, OH · +19 more sites
RecruitingPhase 2NCT05538208The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) StudySponsor: Children's Hospital Medical Center, CincinnatiAkron, OH · Cincinnati, OH · Cleveland, OH · +16 more sites
RecruitingPhase 1 / Phase 2NCT07089121Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune DisordersSponsor: Cartesian TherapeuticsCincinnati, OH · +2 more sites
RecruitingNot applicableNCT06232304Transforming Care for Individuals With Childhood-onset Systemic Lupus ErythematosusSponsor: Michigan State UniversityCincinnati, OH · +5 more sites